Three former employees of Bose Corp. are banking on their audio experience and Ozlo Sleepbuds helping the millions of people who struggle to sleep soundly each night. That prospect is music to the ears of investors Lifearc Ventures and Artis Ventures, who led Ozlo Sleep Inc.’s $10 million round to bring the wireless, in-ear headphones to market in the next few weeks.

US debate over Medicare coverage of novel technologies reaches JAMA

The debate in the U.S. over the process by which the Medicare program covers new medical technologies has intensified over the past three years and has now spilled into the pages of the Journal of the American Medical Association. An article in JAMA asserts that only 44% of novel devices had achieved meaningful coverage and reimbursement milestones within 5.7 years of FDA market authorization, adding yet more pressure on the legislative and executive branches to act to deal with what device makers characterize as the med-tech valley of death.

Plasma biomarkers could help identify teens at risk for mental health conditions

An estimated 10% to 20% of adolescents worldwide struggle with mental health issues. According to the CDC’s most recent Youth Risk Behavior Survey, nearly 60% of teen girls in the U.S. reported feeling sad every day for at least two weeks in the previous year and 22% of high school students considered taking their own lives. Yet despite these alarming trends, the majority of mental health conditions in young people go undiagnosed and untreated. Now, a pilot study by researchers at the University of Eastern Finland offers the prospect of a blood test to identify adolescents at risk of developing mental health problems. 

US FTC touts cooperation with UK, Australia in halting Cooper’s acquisition of Cook unit 

The proposed $875 million acquisition of Cook Medica Inc.’s reproductive health business by Cooper Companies has been scotched, a development lauded by the U.S. Federal Trade Commission in a statement describing the proposed transaction as anticompetitive. However, the FTC statement also points to cooperation from authorities in both the U.K. and Australia as critical in forcing the abandonment of the transaction, a signal that such cooperation is likely to grow in the future.

Novastep acquisition puts Enovis on firm footing

Enovis Corp. announced a definitive agreement to acquire Novastep SAS and its foot and ankle minimally invasive surgical platform for €68 million from Amplitude Surgical SAS. The transaction is expected to close in the second quarter of 2023, subject to customary closing conditions and regulatory approval.

Also in the news

Agilent Technologies, Biophotas, Dario, Element Biosciences, Fesarius Therapeutics, Figur8, Haemonetics, Health Recovery Solutions, Heartbeam, Lumabridge, Nyra Medical, Pentax Medical, Qiagen, Zerigo Health